Use of mycophenolate mofetil for chronic, refractory immune cytopenias in children with autoimmune lymphoproliferative syndrome
Authors:
- Faith DuganFDFaith Dugan
- Janet K. DaleJDJanet K. Dale
- Joie DavisJDJoie Davis
- Jean TretlerJTJean Tretler
- John K. HurleyJHJohn K. Hurley
- Thomas FleisherTFThomas Fleisher
- Jennifer PuckJPJennifer Puck
- Stephen E. StrausSSStephen E. Straus
- 6 May 2005
- journal article
- clinical trial
- Published by Wiley in British Journal of Haematology
- Vol. 129 (4) , 534-538
Abstract
Summary: Autoimmune lymphoproliferative syndrome (ALPS) is a disorder of apoptosis associated most often with heritable FAS mutations leading to lymphadenopathy, hypersplenism and chronic refractory autoimmune cytopenias. Mycophenolate mofetil (MMF) was used to treat cytopenias in 13 ALPS patients aged 9 months to 17 years from a cohort of 118 children (aged < 18 years) and 82 adults. Twelve responded for a median follow‐up of 49 weeks (range 38–240 weeks), defined by maintenance of adequate blood counts and reduction in dosage or cessation of other immunosuppressive agents. This preliminary experience suggests that MMF may spare steroid usage in patients with ALPS‐associated cytopenias.Keywords
This publication has 12 references indexed in Scilit:
- Somatic Mutations — Not Just for Cancer AnymoreNew England Journal of Medicine, 2004
- Autoimmune Lymphoproliferative Syndrome with SomaticFasMutationsNew England Journal of Medicine, 2004
- Long-term outcomes in adults with chronic ITP after splenectomy failureBlood, 2004
- A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantationBone Marrow Transplantation, 2004
- The efficacy and safety of B‐cell depletion with anti‐CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpuraBritish Journal of Haematology, 2004
- Is posttransplant lymphoproliferative disorder (PTLD) caused by any specific immunosuppressive drug or by the transplantation per se?Transplantation, 2003
- Mycophenolate mofetil (MMF) for the treatment of steroid‐resistant idiopathic thrombocytopenic purpuraEuropean Journal of Haematology, 2003
- Mycophenolate mofetil for the treatment of refractory auto‐immune haemolytic anaemia and auto‐immune thrombocytopenia purpuraBritish Journal of Haematology, 2002
- The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosisBlood, 2001
- A BLINDED, LONG-TERM, RANDOMIZED MULTICENTER STUDY OF MYCOPHENOLATE MOFETIL IN CADAVERIC RENAL TRANSPLANTATIONTransplantation, 1998